BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 33417860)

  • 1. Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.
    Rehman SK; Haynes J; Collignon E; Brown KR; Wang Y; Nixon AML; Bruce JP; Wintersinger JA; Singh Mer A; Lo EBL; Leung C; Lima-Fernandes E; Pedley NM; Soares F; McGibbon S; He HH; Pollet A; Pugh TJ; Haibe-Kains B; Morris Q; Ramalho-Santos M; Goyal S; Moffat J; O'Brien CA
    Cell; 2021 Jan; 184(1):226-242.e21. PubMed ID: 33417860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model.
    Moghal N; Li Q; Stewart EL; Navab R; Mikubo M; D'Arcangelo E; Martins-Filho SN; Raghavan V; Pham NA; Li M; Shepherd FA; Liu G; Tsao MS
    J Thorac Oncol; 2023 Apr; 18(4):499-515. PubMed ID: 36535627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
    Chang CA; Jen J; Jiang S; Sayad A; Mer AS; Brown KR; Nixon AML; Dhabaria A; Tang KH; Venet D; Sotiriou C; Deng J; Wong KK; Adams S; Meyn P; Heguy A; Skok JA; Tsirigos A; Ueberheide B; Moffat J; Singh A; Haibe-Kains B; Khodadadi-Jamayran A; Neel BG
    Cancer Discov; 2022 Apr; 12(4):1022-1045. PubMed ID: 34911733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth.
    Chen HL; Jin WL
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
    Kawakami R; Mashima T; Kawata N; Kumagai K; Migita T; Sano T; Mizunuma N; Yamaguchi K; Seimiya H
    Cancer Sci; 2020 Mar; 111(3):962-973. PubMed ID: 31960523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence.
    Dhimolea E; de Matos Simoes R; Kansara D; Al'Khafaji A; Bouyssou J; Weng X; Sharma S; Raja J; Awate P; Shirasaki R; Tang H; Glassner BJ; Liu Z; Gao D; Bryan J; Bender S; Roth J; Scheffer M; Jeselsohn R; Gray NS; Georgakoudi I; Vazquez F; Tsherniak A; Chen Y; Welm A; Duy C; Melnick A; Bartholdy B; Brown M; Culhane AC; Mitsiades CS
    Cancer Cell; 2021 Feb; 39(2):240-256.e11. PubMed ID: 33417832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure.
    Guler GD; Tindell CA; Pitti R; Wilson C; Nichols K; KaiWai Cheung T; Kim HJ; Wongchenko M; Yan Y; Haley B; Cuellar T; Webster J; Alag N; Hegde G; Jackson E; Nance TL; Giresi PG; Chen KB; Liu J; Jhunjhunwala S; Settleman J; Stephan JP; Arnott D; Classon M
    Cancer Cell; 2017 Aug; 32(2):221-237.e13. PubMed ID: 28781121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells.
    Xiong L; Liu Z; Ouyang G; Lin L; Huang H; Kang H; Chen W; Miao X; Wen Y
    Oncotarget; 2017 Jan; 8(4):6419-6432. PubMed ID: 28031534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
    Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
    Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    Lu M; Zessin AS; Glover W; Hsu DS
    PLoS One; 2017; 12(1):e0169439. PubMed ID: 28060954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
    Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells.
    Wei MF; Chen MW; Chen KC; Lou PJ; Lin SY; Hung SC; Hsiao M; Yao CJ; Shieh MJ
    Autophagy; 2014 Jul; 10(7):1179-92. PubMed ID: 24905352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
    Galimi F; Torti D; Sassi F; Isella C; CorĂ  D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A
    Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.
    Arena S; Corti G; Durinikova E; Montone M; Reilly NM; Russo M; Lorenzato A; Arcella P; Lazzari L; Rospo G; Pagani M; Cancelliere C; Negrino C; Isella C; Bartolini A; Cassingena A; Amatu A; Mauri G; Sartore-Bianchi A; Mittica G; Medico E; Marsoni S; Linnebacher M; Abrignani S; Siena S; Di Nicolantonio F; Bardelli A
    Clin Cancer Res; 2020 Mar; 26(6):1372-1384. PubMed ID: 31831554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
    Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
    Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musarin, a novel protein with tyrosine kinase inhibitory activity from Trametes versicolor, inhibits colorectal cancer stem cell growth.
    He Y; Liu S; Newburg DS
    Biomed Pharmacother; 2021 Dec; 144():112339. PubMed ID: 34656057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation.
    Fang DD; Zhang CC; Gu Y; Jani JP; Cao J; Tsaparikos K; Yuan J; Thiel M; Jackson-Fisher A; Zong Q; Lappin PB; Hayashi T; Schwab RB; Wong A; John-Baptiste A; Bagrodia S; Los G; Bender S; Christensen J; Vanarsdale T
    PLoS One; 2013; 8(6):e67258. PubMed ID: 23826249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy.
    Mikubo M; Inoue Y; Liu G; Tsao MS
    J Thorac Oncol; 2021 Nov; 16(11):1798-1809. PubMed ID: 34352380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.